| NCT04977024 | SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer | RECRUITING | PHASE2 | 2021-09-27 | 2027-12-31 | 2026-12-31 |
| NCT04639466 | A Synthetic MVA-based SARS-CoV-2 Vaccine, GEO-CM04S1, for the Prevention of COVID-19 Infection | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2020-11-19 | 2026-02-28 | 2025-10-31 |
| NCT03754933 | Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer | COMPLETED | PHASE1, PHASE2 | 2019-02-11 | 2024-12-31 | 2023-12-29 |
| NCT01378156 | A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 Infected Adults on ART | COMPLETED | PHASE1 | 2010-06 | 2014-05 | 2014-05 |